UBS expressed optimism about PVH (NYSE:PVH), stating that despite facing several macro challenges, the company has the potential to achieve long-term earnings growth due to its strong brand and healthy balance sheet. UBS has raised its price target for PVH from $92 to $115 and maintained its Buy rating.
The firm anticipates a 5-year EPS CAGR of over 15%, and credits CEO Stefan Larsson’s plan to enhance PVH’s profitability. The analyst suggests that PVH’s efforts to enhance its brands, product assortment, direct-to-consumer sales, inventory management, speed-to-market, and cost efficiencies are proving successful and could result in significantly higher financial benefits than previously anticipated.